N-Acetylcysteine (NAC): Impacts on Human Health
Open accessThe DOI matches its Crossref record; 202 of the 205 references it cites were found in a registry or an index.
Abstract
N-acetylcysteine (NAC) is a medicine widely used to treat paracetamol overdose and as a mucolytic compound. It has a well-established safety profile, and its toxicity is uncommon and dependent on the route of administration and high dosages. Its remarkable antioxidant and anti-inflammatory capacity is the biochemical basis used to treat several diseases related to oxidative stress and inflammation. The primary role of NAC as an antioxidant stems from its ability to increase the intracellular concentration of glutathione (GSH), which is the most crucial biothiol responsible for cellular redox imbalance. As an anti-inflammatory compound, NAC can reduce levels of tumor necrosis factor-alpha (TNF-α) and interleukins (IL-6 and IL-1β) by suppressing the activity of nuclear factor kappa B (NF-κB). Despite NAC’s relevant therapeutic potential, in several experimental studies, its effectiveness in clinical trials, addressing different pathological conditions, is still limited. Thus, the purpose of this chapter is to provide an overview of the medicinal effects and applications of NAC to human health based on current therapeutic evidence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Mechanism of molecular action of N-acetylcysteine. Adapted from Aldini et al. (2018) [3].](https://figures.cochat.ai/paper-figures/60af256799034cc58d87ed5cef279acd/n-acetylcysteine-nac-impacts-on-human-health-figure-1.jpg)
![Figure 2 Chemical formula of N-acetylcysteine and its conversion to glutathione. Adapted from Rushworth and Megson (2014) [11].](https://figures.cochat.ai/paper-figures/cab98d412c534fd19add856d05ca0229/n-acetylcysteine-nac-impacts-on-human-health-figure-2.jpg)
![Figure 3 Biological activities and therapeutic uses of N-Acetylcysteine. Adapted from Samuni et al. (2013) [34].](https://figures.cochat.ai/paper-figures/932fb29cb28c4176a2b9ae84e1b4a907/n-acetylcysteine-nac-impacts-on-human-health-figure-3.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“NAC restores glutathione by replenishing cysteine, the ratelimiting factor for glutathione synthesis [96,97].”
From Paracetamol (acetaminophen) overdose and hepatotoxicity: mechanism, treatment, prevention measures, and estimates of burden of disease (2023) · cites this paper as [97]
In the citing paper
“Acetylcysteine is an effective antidote, however despite its use hepatotoxicity and many deaths still occur.”
From Paracetamol (acetaminophen) overdose and hepatotoxicity: mechanism, treatment, prevention measures, and estimates of burden of disease (2023) · cites this paper as [97]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Burden of liver diseases in the world
Asrani, S. K., Devarbhavi, H., Eaton, J., & Kamath, P. S. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.09.014 · Cited by 3,783
Global Initiative for Chronic Obstructive Lung Disease (GOLD)
Rahman, M. M., & Siddiqui, M. M. R. (2017) · Anwer Khan Modern Medical College Journal · doi:10.3329/akmmcj.v7i1.31596 · Cited by 3,106
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
Malfertheiner, P., Megraud, F., O'Morain, C. A., Gisbert, J. P., Kuipers, E. J., Axon, A. T., Bazzoli, F., Gasbarrini, A., Atherton, J., Graham, D. Y., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-312288 · Cited by 2,946
Wallace, D. C. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3365 · Cited by 2,404
Aruoma, O. I., Halliwell, B., Hoey, B. M., & Butler, J. (1989) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(89)90066-x · Cited by 1,772
ACG Clinical Guideline: Treatment of Helicobacter pylori Infection
Chey, W. D., Leontiadis, G. I., Howden, C. W., & Moss, S. F. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2016.563 · Cited by 1,604
Cancer metabolism: a therapeutic perspective
Martinez-Outschoorn, U. E., Peiris-Pagés, M., Pestell, R. G., Sotgia, F., & Lisanti, M. P. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.60 · Cited by 1,505
Oxidative stress as a crucial factor in liver diseases
Cichoż-Lach, H. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i25.8082 · Cited by 1,216
Moghaddam, B., & Javitt, D. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.181 · Cited by 1,035
Chronic obstructive pulmonary disease
Rabe, K. F., & Watz, H. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31222-9 · Cited by 960
The chemistry and biological activities of N-acetylcysteine
Samuni, Y., Goldstein, S., Dean, O. M., & Berk, M. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.04.016 · Cited by 876
N-Acetylcysteine as an antioxidant and disulphide breaking agent: the reasons why
Aldini, G., Altomare, A., Baron, G., Vistoli, G., Carini, M., Borsani, L., & Sergio, F. (2018) · Free Radical Research · doi:10.1080/10715762.2018.1468564 · Cited by 830
Reactivity of biologically important thiol compounds with superoxide and hydrogen peroxide
Winterbourn, C. C., & Metodiewa, D. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00051-9 · Cited by 799 · cited 1×
“4, 25 °C [37] [43] ONOO− 415 ± 10 pH 7.”
Rushworth, G. F., & Megson, I. L. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.09.006 · Cited by 719
Decramer, M., Rutten-van Mölken, M., Dekhuijzen, P. R., Troosters, T., van Herwaarden, C., Pellegrino, R., van Schayck, C. O., Olivieri, D., Del Donno, M., De Backer, W., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66456-2 · Cited by 684
Helicobacter pylori Therapy for the Prevention of Metachronous Gastric Cancer
Choi, I. J., Kook, M.-C., Kim, Y.-I., Cho, S.-J., Lee, J. Y., Kim, C. G., Park, B., & Nam, B.-H. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1708423 · Cited by 673
Improvement by Acetylcysteine of Hemodynamics and Oxygen Transport in Fulminant Hepatic Failure
Harrison, P. M., Wendon, J. A., Gimson, A. E. S., Alexander, G. J. M., & Williams, R. (1991) · New England Journal of Medicine · doi:10.1056/nejm199106273242604 · Cited by 585
Berk, M., Copolov, D., Dean, O., Lu, K., Jeavons, S., Schapkaitz, I., Anderson-Hunt, M., Judd, F., Katz, F., Katz, P., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.03.004 · Cited by 552
N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action
Dean, O., Giorlando, F., & Berk, M. (2011) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.100057 · Cited by 494
(1973) · BMJ · doi:10.1136/bmj.2.5863.432 · Cited by 488
Cantin, A. M., Hubbard, R. C., & Crystal, R. G. (1989) · American Review of Respiratory Disease · doi:10.1164/ajrccm/139.2.370 · Cited by 468
Farace, C., Melguizo, C., Asara, Y., Álvarez, P., Prados, J. C., Tolu, P., Delogu, G., Aránega, A., & Madeddu, R. (2011) · Cited by 464
Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review
Deepmala, Slattery, J., Kumar, N., Delhey, L., Berk, M., Dean, O., Spielholz, C., & Frye, R. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.04.015 · Cited by 463
Molecular basis of NMDA receptor functional diversity
Paoletti, P. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07628.x · Cited by 451
N -acetylcysteine for antioxidant therapy: pharmacology and clinical utility
Dodd, S., Dean, O., Copolov, D. L., Malhi, G. S., & Berk, M. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14728220802517901 · Cited by 413
Glucocorticoids plus N-Acetylcysteine in Severe Alcoholic Hepatitis
Nguyen-Khac, E., Thevenot, T., Piquet, M.-A., Benferhat, S., Goria, O., Chatelain, D., Tramier, B., Dewaele, F., Ghrib, S., Rudler, M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1101214 · Cited by 410
N‐acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities
Bavarsad Shahripour, R., Harrigan, M. R., & Alexandrov, A. V. (2014) · Brain and Behavior · doi:10.1002/brb3.208 · Cited by 410
Ezeriņa, D., Takano, Y., Hanaoka, K., Urano, Y., & Dick, T. P. (2018) · Cell Chemical Biology · doi:10.1016/j.chembiol.2018.01.011 · Cited by 403
Evidence that reactive oxygen species do not mediate NF- B activation
Hayakawa, M. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg332 · Cited by 381
Glutathione Precursor, N-Acetyl-Cysteine, Improves Mismatch Negativity in Schizophrenia Patients
Lavoie, S., Murray, M. M., Deppen, P., Knyazeva, M. G., Berk, M., Boulat, O., Bovet, P., Bush, A. I., Conus, P., Copolov, D., et al. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301624 · Cited by 371
Clinical Pharmacokinetics of N-Acetylcysteine
Holdiness, M. R. (1991) · Clinical Pharmacokinetics · doi:10.2165/00003088-199120020-00004 · Cited by 359
Pharmacokinetics and bioavailability of reduced and oxidized N-acetylcysteine
Olsson, B., Johansson, M., Gabrielsson, J., & Bolme, P. (1988) · European Journal of Clinical Pharmacology · doi:10.1007/bf01061422 · Cited by 351
Pharmacokinetics of N-acetylcysteine in man
Borgstr�m, L., K�gedal, B., & Paulsen, O. (1986) · European Journal of Clinical Pharmacology · doi:10.1007/bf00606662 · Cited by 342
Prütz, W. A., Mönig, H., Butler, J., & Land, E. J. (1985) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(85)90780-5 · Cited by 337
Sadowska, A. M., Manuel-y-Keenoy, B., & De Backer, W. A. (2007) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2005.12.007 · Cited by 325
Pathogenesis and clinical management of Helicobacter pylori gastric infection
Brito, B. B. D., Silva, F. A. F. D., Soares, A. S., Pereira, V. A., Santos, M. L. C., Sampaio, M. M., Neves, P. H. M., & Melo, F. F. D. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i37.5578 · Cited by 291
Overview on the Effects of N-Acetylcysteine in Neurodegenerative Diseases
Tardiolo, G., Bramanti, P., & Mazzon, E. (2018) · Molecules · doi:10.3390/molecules23123305 · Cited by 285
Miranda, K. M., Paolocci, N., Katori, T., Thomas, D. D., Ford, E., Bartberger, M. D., Espey, M. G., Kass, D. A., Feelisch, M., Fukuto, J. M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1430507100 · Cited by 283
Zheng, J.-P., Wen, F.-Q., Bai, C.-X., Wan, H.-Y., Kang, J., Chen, P., Yao, W.-Z., Ma, L.-J., Li, X., Raiteri, L., et al. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70286-8 · Cited by 258
High-dose oral N -acetylcysteine, a glutathione prodrug, modulates inflammation in cystic fibrosis
Tirouvanziam, R., Conrad, C. K., Bottiglieri, T., Herzenberg, L. A., Moss, R. B., & Herzenberg, L. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511304103 · Cited by 253
Oxidative Stress and Inflammation in Hepatic Diseases: Therapeutic Possibilities of N-Acetylcysteine
De Andrade, K., Moura, F., Dos Santos, J., De Araújo, O., De Farias Santos, J., & Goulart, M. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161226225 · Cited by 253
Self-citationFord, E., Hughes, M. N., & Wardman, P. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00850-x · Cited by 229
A minireview on N -acetylcysteine: An old drug with new approaches
Elbini Dhouib, I., Jallouli, M., Annabi, A., Gharbi, N., Elfazaa, S., & Lasram, M. M. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.03.003 · Cited by 221
N-acetylcysteine Boosts Brain and Blood Glutathione in Gaucher and Parkinson Diseases
Holmay, M. J., Terpstra, M., Coles, L. D., Mishra, U., Ahlskog, M., Öz, G., Cloyd, J. C., & Tuite, P. J. (2013) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e31829ae713 · Cited by 216
Influence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysis
Cazzola, M., Calzetta, L., Page, C., Jardim, J., Chuchalin, A. G., Rogliani, P., & Gabriella Matera, M. (2015) · European Respiratory Review · doi:10.1183/16000617.00002215 · Cited by 198
Rationale for the use of N ‐acetylcysteine in both prevention and adjuvant therapy of COVID‐19
De Flora, S., Balansky, R., & La Maestra, S. (2020) · The FASEB Journal · doi:10.1096/fj.202001807 · Cited by 189
High-Dose N-Acetylcysteine in Stable COPD
Tse, H. N., Raiteri, L., Wong, K. Y., Yee, K. S., Ng, L. Y., Wai, K. Y., Loo, C. K., & Chan, M. H. (2013) · Chest · doi:10.1378/chest.12-2357 · Cited by 187
Mitochondria, Metabolism, and Redox Mechanisms in Psychiatric Disorders
Kim, Y., Vadodaria, K. C., Lenkei, Z., Kato, T., Gage, F. H., Marchetto, M. C., & Santos, R. (2019) · Antioxidants & Redox Signaling · doi:10.1089/ars.2018.7606 · Cited by 187
The disposition and kinetics of intravenous N-acetylcysteine in patients with paracetamol overdosage
Prescott, L. F., Donovan, J. W., Jarvie, D. R., & Proudfoot, A. T. (1989) · European Journal of Clinical Pharmacology · doi:10.1007/bf00558131 · Cited by 185
Trujillo, M., & Radi, R. (2002) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2619 · Cited by 179
Oxidative Stress in Parkinson’s Disease: Potential Benefits of Antioxidant Supplementation
Percário, S., Barbosa, A. D. S., Varela, E. L. P., Gomes, A. R. Q., Ferreira, M. E. S., Moreira, T. D. N. A., & Dolabela, M. F. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/2360872 · Cited by 175
Berk, M., Dean, O. M., Cotton, S. M., Jeavons, S., Tanious, M., Kohlmann, K., Hewitt, K., Moss, K., Allwang, C., Schapkaitz, I., et al. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13m08454 · Cited by 172
Jannatifar, R., Parivar, K., Roodbari, N. H., & Nasr‐Esfahani, M. H. (2019) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-019-0468-9 · Cited by 172
Coles, L. D., Tuite, P. J., Öz, G., Mishra, U. R., Kartha, R. V., Sullivan, K. M., Cloyd, J. C., & Terpstra, M. (2018) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1008 · Cited by 170
Rogliani, P., Calzetta, L., Cavalli, F., Matera, M. G., & Cazzola, M. (2016) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2016.07.009 · Cited by 168
Epidemiology, Diagnosis and Risk Factors of Helicobacter pylori Infection
Kotilea, K., Bontems, P., & Touati, E. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/5584_2019_357 · Cited by 168
Biological Activities and Potential Oral Applications of N‐Acetylcysteine: Progress and Prospects
Pei, Y., Liu, H., Yang, Y., Yang, Y., Jiao, Y., Tay, F. R., & Chen, J. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/2835787 · Cited by 165
Conus, P., Seidman, L. J., Fournier, M., Xin, L., Cleusix, M., Baumann, P. S., Ferrari, C., Cousins, A., Alameda, L., Gholam-Rezaee, M., et al. (2018) · Schizophrenia Bulletin · doi:10.1093/schbul/sbx093 · Cited by 162
Anti-inflammatory properties of N-acetylcysteine on lipopolysaccharide-activated macrophages
Palacio, J. R., Markert, U. R., & Martínez, P. (2011) · Inflammation Research · doi:10.1007/s00011-011-0323-8 · Cited by 160
Pasupathy, S., Tavella, R., Grover, S., Raman, B., Procter, N. E. K., Du, Y., Mahadavan, G., Stafford, I., Heresztyn, T., Holmes, A. S., et al. (2017) · Circulation · doi:10.1161/circulationaha.117.027575 · Cited by 160
Özaydın, M., Peker, O., Erdoğan, D., Kapan, S., Türker, Y., Varol, E., Ozguner, F., Doğan, A. F., & İbrişim, E. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn011 · Cited by 158
Review: Epidemiology of Helicobacter pylori infection
Leja, M., Grinberga‐Derica, I., Bilgilier, C., & Steininger, C. (2019) · Helicobacter · doi:10.1111/hel.12635 · Cited by 158
Farokhnia, M., Azarkolah, A., Adinehfar, F., Khodaie-Ardakani, M.-R., Hosseini, S.-M.-R., Yekehtaz, H., Tabrizi, M., Rezaei, F., Salehi, B., Sadeghi, S.-M.-H., et al. (2013) · Clinical Neuropharmacology · doi:10.1097/wnf.0000000000000001 · Cited by 155
Arstall, M. A., Yang, J., Stafford, I., Betts, W. H., & Horowitz, J. D. (1995) · Circulation · doi:10.1161/01.cir.92.10.2855 · Cited by 155
Santus, P., Corsico, A. G., Solidoro, P., Braido, F., Marco, F. D., & Scichilone, N. (2014) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2014.898040 · Cited by 155
Idiopathic Pulmonary Fibrosis: Current Status, Recent Progress, and Emerging Targets
Liu, Y.-M., Nepali, K., & Liou, J. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00935 · Cited by 154
Updated guidelines for the management of paracetamol poisoning in Australia and New Zealand
Chiew, A. L., Reith, D., Pomerleau, A., Wong, A., Isoardi, K. Z., Soderstrom, J., & Buckley, N. A. (2020) · Medical Journal of Australia · doi:10.5694/mja2.50428 · Cited by 145
The reaction of superoxide radical with N-acetylcysteine
Benrahmoune, M., Thérond, P., & Abedinzadeh, Z. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00380-4 · Cited by 143
N-Acetylcysteine: A potential therapeutic agent for SARS-CoV-2
Poe, F. L., & Corn, J. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.109862 · Cited by 134
Homma, S. A., Azuma, A., Taniguchi, H., Ogura, T., Mochiduki, Y., Sugiyama, Y., Nakata, K., Yoshimura, K., Takeuchi, M., & Kudoh, S. (2012) · Respirology · doi:10.1111/j.1440-1843.2012.02132.x · Cited by 131
de Farias, C. C., Maes, M. H. J., Bonifácio, K. L., Bortolasci, C. C., Souza-Nogueira, A., Brinholi, F. F., Matsumoto, A. K., do Nascimento, M. A., de Melo, L. B., Nixdorf, S. L., et al. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.02.011 · Cited by 130
Moreno, C., Langlet, P., Hittelet, A., Lasser, L., Degré, D., Evrard, S., Colle, I. O., Lemmers, A., Deviere, J. M. E., & Moine, O. L. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.05.030 · Cited by 122
Amaral, E. P., Conceição, E. L., Costa, D. L., Rocha, M. S., Marinho, J. M., Cordeiro‐Santos, M., Lima, M. R. D., Barbosa, T., Sher, A., & Andrade, B. B. (2016) · BMC Microbiology · doi:10.1186/s12866-016-0872-7 · Cited by 122
N‐Acetyl Cysteine Is Associated With Dopaminergic Improvement in Parkinson's Disease
Monti, D. A., Zabrecky, G., Kremens, D., Liang, T., Wintering, N. A., Bazzan, A. J., Zhong, L., Bowens, B. K., Chervoneva, I., Intenzo, C., et al. (2019) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1548 · Cited by 121
Toxicological, pharmacokinetic and metabolic studies on acetylcysteine.
Bonanomi, L., & Gazzaniga, A. (1980) · PubMed · Cited by 119
Choi, I.-Y., Lee, S.-P., Denney, D. R., & Sg, L. (2010) · Multiple Sclerosis Journal · doi:10.1177/1352458510384010 · Cited by 118
Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis
Tam, J. S., Nash, E. F., Ratjen, F. A., Tullis, E. D., & Stephenson, A. L. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007168.pub3 · Cited by 112
Combined use of nitroglycerin and N-acetylcysteine in the management of unstable angina pectoris.
Horowitz, J. D., Henry, C. A., Syrjanen, M. L., Louis, W. J., Fish, R. D., Smith, T. W., & Antman, E. M. (1988) · Circulation · doi:10.1161/01.cir.77.4.787 · Cited by 112
N-Acetylcysteine prevents congenital heart defects induced by pregestational diabetes
Moazzen, H., Lu, X., Ma, N. L., Velenosi, T. J., Urquhart, B. L., Wisse, L. J., Gittenberger-de Groot, A. C., & Feng, Q. (2014) · Cardiovascular Diabetology · doi:10.1186/1475-2840-13-46 · Cited by 111
Xie, C., Yi, J., Lü, J., Nie, M., Huang, M., Rong, J., Zhu, Z., Chen, J., Zhou, X., Li, B., et al. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/1874985 · Cited by 110
Nabi, T., Nabi, S., Rafiq, N., & Shah, A. (2017) · Saudi Journal of Gastroenterology · doi:10.4103/1319-3767.207711 · Cited by 109
N-acetylcysteine in acute cardiology: 10 years later
SOCHMAN, J. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01797-7 · Cited by 106
N-Acetylcysteine for the Treatment of Psychiatric Disorders: A Review of Current Evidence
Ooi, S. L., Green, R., & Pak, S. C. (2018) · BioMed Research International · doi:10.1155/2018/2469486 · Cited by 105
Effects of N ‐acetylcysteine on dense cell formation in sickle cell disease
Pace, B. S., Shartava, A., Pack-Mabien, A. V., Mulekar, M., Ardia, A., & Goodman, S. R. (2003) · American Journal of Hematology · doi:10.1002/ajh.10321 · Cited by 103
Impact of Mucolytic Agents on COPD Exacerbations: A Pair-wise and Network Meta-analysis
Cazzola, M., Rogliani, P., Calzetta, L., Hanania, N., & Matera, M. (2017) · COPD · doi:10.1080/15412555.2017.1347918 · Cited by 102
Magalhães, P. V. D. S., Dean, O. M., Bush, A. I., Copolov, D., Malhi, G. S., Kohlmann, K., Jeavons, S., Schapkaitz, I., Anderson‐Hunt, M., & Berk, M. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.08.001 · Cited by 101
Berk, M., Turner, A., Malhi, G. S., Ng, C. H., Cotton, S., Dodd, S., Samuni, Y., Tanious, M., McAulay, C., Dowling, N. L., et al. (2019) · BMC Medicine · doi:10.1186/s12916-019-1257-1 · Cited by 100
N-acetylcysteine reduces oxidative stress in sickle cell patients
on behalf of the CURAMA study group, Nur, E., Brandjes, D. P. M., Teerlink, T., Otten, H.-M. M. B., Elferink, R. P. J. O., Muskiet, F. A. J., Evers, L. M., Cate, H. T., Biemond, B. J., et al. (2012) · Annals of Hematology · doi:10.1007/s00277-011-1404-z · Cited by 98
Sepehrmanesh, Z., Heidary, M., Akasheh, N., Akbari, H., & Heidary, M. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.11.001 · Cited by 98
Yoo, J. J., Hamilton, S. J., Angel, D., Fung, K., Franklin, J. H., Parnes, L. S., Lewis, D., Venkatesan, V., & Winquist, E. (2013) · The Laryngoscope · doi:10.1002/lary.24360 · Cited by 97
Use of N-acetylcysteine to reduce post-cardiothoracic surgery complications: a meta-analysis
Baker, W. L., Anglade, M. W., Baker, E. L., White, C. M., Kluger, J., & Coleman, C. I. (2009) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2008.11.027 · Cited by 97
Molecular Pathways: Trafficking of Metabolic Resources in the Tumor Microenvironment
Romero, I. L., Mukherjee, A., Kenny, H. A., Litchfield, L. M., & Lengyel, E. R. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2198 · Cited by 94
Medicinal Thiols: Current Status and New Perspectives
Pfaff, A. R., Beltz, J., King, E., & Nuran Ercal, A. (2019) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557519666191119144100 · Cited by 91
Beneficial effects of n‐acetylcysteine on ischaemic brain injury
Cuzzocrea, S., Mazzon, E., Costantino, G., Serraino, I., Dugo, L., Calabrò, G., Cucinotta, G., Sarro, A. D., & Caputi, A. P. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703421 · Cited by 87
N-acetylcysteine improves liver function in patients with non-alcoholic Fatty liver disease.
Khoshbaten, M., Aliasgarzadeh, A., Masnadi, K., Tarzamani, M. K., Farhang, S., Babaei, H., Kiani, J., Nahandi, M. Z., & Najafipoor, F. (2010) · PubMed Central · Cited by 87
Lee, T.-M., Lee, K.-M., Lee, C.-Y., Lee, H., Tam, K., & Loh, E. (2020) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867420952540 · Cited by 86
Safety of N-Acetylcysteine at High Doses in Chronic Respiratory Diseases: A Review
CALVERLEY, P. M. A., Rogliani, P., & Papi, A. A. (2020) · Drug Safety · doi:10.1007/s40264-020-01026-y · Cited by 84
Carmeli, C., Knyazeva, M. G., Cuénod, M., & Do, K. Q. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029341 · Cited by 81
The Toxicology Investigator Network (2010) · Clinical Toxicology · doi:10.3109/15563650.2010.486381 · Cited by 81
N-acetylcysteine overdose after acetaminophen poisoning
Astaraki, P., Mahmoudi, G. A., Mohtashami, A. Z., & Ahadi, M. (2015) · International Medical Case Reports Journal · doi:10.2147/imcrj.s74563 · Cited by 79
Magnetic Resonance Spectroscopy Study of the Antioxidant Defense System in Schizophrenia
Matsuzawa, D., & Hashimoto, K. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3453 · Cited by 79
Dludla, P. V., Nkambule, B. B., Mazibuko-Mbeje, S. E., Nyambuya, T. M., Marcheggiani, F., Cirilli, I., Ziqubu, K., Shabalala, S. C., Johnson, R., Louw, J., et al. (2020) · Antioxidants · doi:10.3390/antiox9121283 · Cited by 78
N‐acetylcysteine for non‐paracetamol drug‐induced liver injury: a systematic review
Chughlay, M. F., Kramer, N., Spearman, C. W., Werfalli, M., & Cohen, K. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12880 · Cited by 76
Critical Care Toxicology: Diagnosis and Management of the Critically Poisoned Patient
White, J., PALMER, R. B., Mégarbane, B., Hatten, B. W., Dargan, P. I., Burkhart, K., & Brent, J. A. (2017) · Springer eBooks · doi:10.1007/978-3-319-17900-1 · Cited by 75
Fluticasone and N-acetylcysteine in primary care patients with COPD or chronic bronchitis
Schermer, T. R., Chavannes, N. H., Dekhuijzen, R. P. N., Wouters, E. F. �., Muris, J. W. M., Akkermans, R. L. C., van Schayck, O. C. P., & van Weel, C. (2009) · Respiratory Medicine · doi:10.1016/j.rmed.2008.11.003 · Cited by 73
Jenkins, D., Wiest, D. B., Mulvihill, D. M., Hlavacek, A. M., Majstoravich, S. J., Brown, T. R., Taylor, J. J., Buckley, J. R., Turner, R. P., Rollins, L. G., et al. (2015) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2015.09.076 · Cited by 71
Oxidative Stress-Related Biomarkers in Multiple Sclerosis: A Review
Ibitoye, R. T., Kemp, K. C., Rice, C. M., Hares, K. M., Scolding, N. J., & Wilkins, A. (2016) · Biomarkers in Medicine · doi:10.2217/bmm-2016-0097 · Cited by 71
N-Acetylcysteine as a Potential Treatment for COVID-19
Rangel-Méndez, J. A., & Moo-Puc, R. E. (2020) · Future Microbiology · doi:10.2217/fmb-2020-0074 · Cited by 70
N-acetylcysteine in dermatology
Adil, M., Amin, S. S., & Mohtashim, M. (2018) · Indian Journal of Dermatology Venereology and Leprology · doi:10.4103/ijdvl.ijdvl_33_18 · Cited by 68
Hara, Y., Fillit, H. M., Dacks, P. A., & McKeehan, N. (2017) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2017.22 · Cited by 66
Meurer, S. K., Lahme, B., Tihaa, L., Weiskirchen, R., & Gressner, A. M. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.07.001 · Cited by 65
Monti, D., Sotgia, F., Whitaker‐Menezes, D., Tuluc, M., Birbe, R., Berger, A. C., Lazar, M. A., Cotzia, P., Draganova‐Tacheva, R., Lin, Z., et al. (2017) · Seminars in Oncology · doi:10.1053/j.seminoncol.2017.10.001 · Cited by 65
Sucu, N., Cinel, İ., Ünlü, A., Aytaçoğlu, B. N., Tamer, L., Kocak, Z., Karaca, K., Gul, A., Dikmengil, M., Atik, U., et al. (2004) · Surgery Today · doi:10.1007/s00595-003-2699-8 · Cited by 64
Darweesh, S. K., Ibrahim, M. F., & Eltahawy, M. (2017) · Clinical Drug Investigation · doi:10.1007/s40261-017-0505-4 · Cited by 63
Anaphylactoid Reactions to Intravenous N-Acetylcysteine during Treatment for Acetaminophen Poisoning
Yarema, M. C., Chopra, P., Sivilotti, M. L. A., Johnson, D. W., Nettel‐Aguirre, A., Bailey, B., Victorino, C., Gosselin, S., Purssell, R. A., Thompson, M. W., et al. (2018) · Journal of Medical Toxicology · doi:10.1007/s13181-018-0653-9 · Cited by 63
Deng, J., Liu, A., Hou, G., Zhang, X., Ren, K., Chen, X.-Z., Li, S. S. ‐., Wu, Y., & Cao, X. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-1016-8 · Cited by 63
Yeşilbursa, D., Serdar, A., Şentürk, T., Serdar, Z., Sağ, S., & Cordan, J. (2006) · Heart and Vessels · doi:10.1007/s00380-005-0854-4 · Cited by 62
Efficacy of N-Acetylcysteine in Idiopathic Pulmonary Fibrosis
Sun, T., Liu, J., & Zhao, D. W. (2016) · Medicine · doi:10.1097/md.0000000000003629 · Cited by 59
Antioxidant supplementation for lung disease in cystic fibrosis
Ciofu, O., & Lykkesfeldt, J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007020.pub3 · Cited by 58
Walayat, S. (2021) · Annals of Gastroenterology · doi:10.20524/aog.2021.0571 · Cited by 58
Wiest, D. B., Chang, E., Fanning, D., Garner, S. S., Cox, T. H., & Jenkins, D. (2014) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2014.06.044 · Cited by 57
Shen, Y., Cai, W., Lei, S., & Zhang, Z. (2013) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2013.858315 · Cited by 56
Improvement of cognitive function in schizophrenia withN-acetylcysteine: A theoretical review
Yolland, C. O. B., Phillipou, A., Castle, D. J., Neill, E., Hughes, M. E., Galletly, C. A., Smith, Z. M., Francis, P. S., Dean, O. M., Sarris, J. J., et al. (2018) · Nutritional Neuroscience · doi:10.1080/1028415x.2018.1478766 · Cited by 56
Guijarro, L. G., Mate, J., Gisbert, J. P., Pérez-Calle, J. L., Marín‐Jiménez, I., Arriaza, E., Olleros, T., Delgado, M., Castillejo, M., Prieto‐Merino, D., et al. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.2851 · Cited by 55
Fowdar, K., Chen, H., He, Z., Zhang, J., Zhong, X.-N., Zhang, J., Li, M., & Bai, J. (2017) · Heart & Lung · doi:10.1016/j.hrtlng.2016.12.004 · Cited by 55
Estensen, R. D., Levy, M., Klopp, S. J., Galbraith, A. R., Mandel, J. S., Blomquist, J. A., & Wattenberg, L. W. (1999) · Cancer Letters · doi:10.1016/s0304-3835(99)00281-5 · Cited by 54
Remington, R., Lortie, J. J., Hoffmann, H., Page, R., Morrell, C., & Shea, T. B. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150057 · Cited by 52
Rodenstein, D. O., Coster, A. D., & Gazzaniga, A. (1978) · Clinical Pharmacokinetics · doi:10.2165/00003088-197803030-00005 · Cited by 51
N-Acetylcysteine Decreases Angiotensin II Receptor Binding in Vascular Smooth Muscle Cells
Ullian, M. E., Gelasco, A. K., Fitzgibbon, W. R., Beck, C., & Morinelli, T. A. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004060458 · Cited by 50
Antioxidant supplementation for lung disease in cystic fibrosis
Ciofu, O., Smith, S. J., & Lykkesfeldt, J. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007020.pub4 · Cited by 49
Roes, E. M., Raijmakers, M. T. M., de Boo, T. M., Zusterzeel, P. L. M., Merkus, H. M. W. M., Peters, W. H. M., & Steegers, E. A. P. (2005) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2005.09.007 · Cited by 47
Niewoehner, D. E., Johnson, K., McEvoy, C., Naqvi, S., Wendt, C. H., Reilkoff, R., Kunisaki, K. M., Wetherbee, E., Nelson, D. B., & Tirouvanziam, R. M. (2016) · International Journal of COPD · doi:10.2147/copd.s102375 · Cited by 47
Santos, E. S., Gowdak, L. H. W., Gaiotto, F. A., Puig, L. B., Hajjar, L. A., Zeferino, S. P., Drager, L. F., Shimizu, M. H. M., Bortolotto, L. A., & Lima, J. J. G. D. (2014) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2014.01.056 · Cited by 46
Perspective: Prospects for Nutraceutical Support of Intestinal Barrier Function
McCarty, M. F., & Lerner, A. (2020) · Advances in Nutrition · doi:10.1093/advances/nmaa139 · Cited by 46
Efficacy of Topical N -Acetylcysteine in the Treatment of Meibomian Gland Dysfunction
Salman, İ. A., Azizi, S., Mumcu, U., & Baykal, O. (2010) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2010.0001 · Cited by 44
Skov, M., Pressler, T., Lykkesfeldt, J., Poulsen, H. E., Jensen, P. Ø., Johansen, H. K., Qvist, T., Kræmer, D., Høiby, N., & Ciofu, O. (2014) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2014.09.015 · Cited by 44
Effects of N-acetylcysteine on brain glutamate levels and resting perfusion in schizophrenia
McQueen, G., Lally, J., Collier, T., Zelaya, F. O., Lythgoe, D. J., Barker, G. J., Stone, J. M., McGuire, P. K., MacCabe, J. H., & Egerton, A. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4997-2 · Cited by 44
Fen, F., Zhang, J., Wang, Z., Wu, Q., & Zhou, X. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.7579 · Cited by 42
Over-the-counter anti-oxidant therapies for use in multiple sclerosis: A systematic review
Plemel, J. R., Juźwik, C. A., Benson, C. A., Monks, M. R., Harris, C. A., & Ploughman, M. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458515601513 · Cited by 41
McColl, A. J., Keeble, T., Hadjinikolaou, L., Cohen, A., Aitkenhead, H., Glenville, B., & Richmond, W. (1998) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/000456329803500504 · Cited by 41
Kishi, T., Miyake, N., Okuya, M., Sakuma, K., & Iwata, N. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05629-2 · Cited by 41
Retsa, C., Knebel, J., Geiser, E., Ferrari, C., Jenni, R., Fournier, M., Alameda, L., Baumann, P., Clarke, S., Conus, P., et al. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.07.008 · Cited by 40
Buhimschi, C. S., Bahtiyar, M. O., Zhao, G., Abdelghany, O., Schneider, L., Abdel‐Razeq, S. S., Dulay, A. T., Lipkind, H. S., Mieth, S., Rogers, L. K., et al. (2020) · Pediatric Research · doi:10.1038/s41390-020-01106-w · Cited by 40
Lee, Y., Lee, D. M., Lee, C.-H., Heo, S.-H., Won, S. Y., Im, J.-H., Cho, M. K., Nam, H.-S., & Lee, S.-H. (2010) · Toxicology in Vitro · doi:10.1016/j.tiv.2010.10.020 · Cited by 39
N-acetylcysteine as an anti-oxidant and anti-inflammatory drug and its some clinical applications
Radomska-Leśniewska, D. M., & Skopiński, P. (2012) · Cited by 39
Pereira, J. E. G., Dib, R. E., Braz, L. G., Escudero, J., Hayes, J., & Johnston, B. C. (2019) · PLoS ONE · doi:10.1371/journal.pone.0213862 · Cited by 39
Preventing Colitis-Associated Colon Cancer With Antioxidants: A Systematic Review
Irrazábal, T., Thakur, B. K., Croitoru, K., & Martín, A. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2020.12.013 · Cited by 39
Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis
Nash, E. F., Stephenson, A. L., Ratjen, F. A., & Tullis, E. D. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007168.pub2 · Cited by 38
Effect of pH on the Reactivity of the Carbonate Radical in Aqueous Solution
Chen, S., & Hoffman, M. Z. (1975) · Radiation Research · doi:10.2307/3574180 · Cited by 37
Nolin, T. D., Ouseph, R., Himmelfarb, J., McMenamin, M., & Ward, R. A. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00210110 · Cited by 37
Yang, C., Bosker, F. J., Li, J., & Schoevers, R. A. (2018) · BMC Psychiatry · doi:10.1186/s12888-018-1845-1 · Cited by 37
Liou, G., Hsieh, C.-C., Lee, Y., Li, P., Tsai, M., Li, C.-T., & Wang, S. (2021) · Antioxidants · doi:10.3390/antiox10030442 · Cited by 37
Mahakalkar, S. M., Nagrale, D., Gaur, S., Urade, C. S., Murhar, B., & Turankar, A. V. (2017) · Perspectives in Clinical Research · doi:10.4103/2229-3485.210450 · Cited by 36
Gu, W., Wu, Z., Wang, P., Aung, L. H. H., & Yin, R. (2012) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-12-10 · Cited by 35
The Potential Role of N-Acetylcysteine for the Treatment of Helicobacter pylori
Makipour, K., & Friedenberg, F. K. (2011) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31822be4d6 · Cited by 34
Kasperczyk, S., Dobrakowski, M., Kasperczyk, A., Romuk, E. B., Rykaczewska-Czerwińska, M., Pawlas, N., & Birkner, E. (2015) · Toxicology and Industrial Health · doi:10.1177/0748233715571152 · Cited by 34
Monti, D., Zabrecky, G. P., Leist, T. P., Wintering, N., Bazzan, A. J., Zhan, T., & Newberg, A. B. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00088 · Cited by 34
Pharmacokinetics of N‐acetylcysteine are altered in patients with chronic liver disease
JONES, A. L., Jarvie, D. R., SIMPSON, D., Hayes, P. C., & Prescott, L. F. (1997) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1997.00209.x · Cited by 33
Papi, A. A., Stefano, A. F. D. D., & Radicioni, M. M. (2020) · Advances in Therapy · doi:10.1007/s12325-020-01542-4 · Cited by 33
Antioxidant effects of N‐acetylcysteine on the male reproductive system: A systematic review
Ghafarizadeh, A., Malmir, M., Noreini, S. N., & Faraji, T. (2020) · Andrologia · doi:10.1111/and.13898 · Cited by 33
Manfredi, G., Bertè, R., Iiritano, E., Alicante, S., Londoni, C., Brambilla, G., Romeo, S., Menozzi, F., Griffanti, P., Brandi, G., et al. (2021) · Endoscopy International Open · doi:10.1055/a-1315-0114 · Cited by 32
Mei, M., Zhao, H., Pan, Q., Pu, Y., Tang, M., & Shen, B. (2017) · Journal of Investigative Surgery · doi:10.1080/08941939.2016.1269853 · Cited by 31
N-acetylcysteine as an adjuvant therapy for Helicobacter pylori eradication
Fontes, L. E. S., Martimbianco, A. L. C., Zanin, C. G., & Riera, R. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012357.pub2 · Cited by 31
Romagnoli, C., Marcucci, T., Picariello, L., Tonelli, F., VINCENZINI, M. T., & Iantomasi, T. (2012) · International Journal of Colorectal Disease · doi:10.1007/s00384-012-1632-2 · Cited by 29
Effect of N‐acetylcysteine on renal function in patients with chronic kidney disease
Mainra, R., Gallo, K., & MOIST, L. M. (2007) · Nephrology · doi:10.1111/j.1440-1797.2007.00833.x · Cited by 29
Paliogiannis, P., Fois, A. G., Collu, C., Bandinu, A., Zinellu, E., Carru, C., Pirina, P., Mangoni, A. A., & Zinellu, A. (2018) · Biomarkers in Medicine · doi:10.2217/bmm-2018-0108 · Cited by 29
Greene, S. C., Noonan, P. K., Sanabria, C. R., & Peacock, W. F. (2016) · Current Therapeutic Research · doi:10.1016/j.curtheres.2016.06.001 · Cited by 27
Salman, İ. A., Azizi, S., Mumcu, U., Ateş, O., & Baykal, O. (2011) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2010.0110 · Cited by 25
Poncin, S., Colin, I. M., Decallonne, B., Clinckspooor, I., Many, M., Denef, J., & Gérard, A.-C. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.091253 · Cited by 24
N-Acetylcysteine in Chronic Blepharitis
Yalçın, E., Altın, F., Cinhüseyinoglue, F., & Arslan, M. O. (2002) · Cornea · doi:10.1097/00003226-200203000-00007 · Cited by 23
Improved oxidative status in major abdominal surgery patients after N-acetyl cystein supplementation
Kuyumcu, A., Akyol, A., Büyüktuncer, Z., Özmen, M. M., & Besler, H. T. (2015) · Nutrition Journal · doi:10.1186/1475-2891-14-4 · Cited by 23
Effect of N-Acetylcysteine on Metabolic Profile in Metabolic Syndrome Patients
Rani, M., Aggarwal, R., & Vohra, K. (2020) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2020.0017 · Cited by 22
N -Acetylcysteine on Its Way to A Broader Application in Patients With Acute Liver Failure
Koch, A. H., & Trautwein, C. (2009) · Hepatology · doi:10.1002/hep.23484 · Cited by 21
N-acetylcysteine as an adjuvant therapy for Helicobacter pylori eradication
Fontes, L. E. S., Batista, C. S., Martimbianco, A. L. C., Zanin, C. G., & Riera, R. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012357 · Cited by 21
N-acetylcysteine as an adjunctive treatment for smoking cessation: a randomized clinical trial
Machado, R. C. B. R., Vargas, H. O., Baracat, M. M., Urbano, M. R., Verri, W. A., Jr., Porcu, M., & Nunes, S. O. V. (2020) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2019-0753 · Cited by 21
The effects of N‐acetyl cysteine on oxidative stress among patients with pre‐eclampsia
Motawei, S. M., Attalla, S. M., Gouda, H. E., Harouny, M. A., & EL-Mansoury, A. (2016) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2016.07.002 · Cited by 19
Sio, T. T. W., Blanchard, M. J., Novotny, P. J., Patel, S. H., Rwigema, J.-C. M., Pederson, L., McGee, L. A., Gamez, M. E., Seeger, G. R., Martenson, J. A., et al. (2019) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2019.03.031 · Cited by 19
An Additive Effect of Oral N-Acetyl Cysteine on Eradication ofHelicobacter pylori
Hamidian, S. M. T., Aletaha, N., Taslimi, R., & Montazeri, M. (2015) · Journal of Pathogens · doi:10.1155/2015/540271 · Cited by 18
N-Acetylcysteine Improves Arterial Vascular Reactivity in Patients with Chronic Kidney Disease
Wittstock, A., Burkert, M., Zidek, W., Tepel, M., & Scholze, A. (2009) · Nephron Clinical Practice · doi:10.1159/000218107 · Cited by 18
N-acetylcysteine prevents the development of gastritis induced by Helicobacter pylori infection
Jang, S., Bak, E., & Cha, J. (2017) · The Journal of Microbiology · doi:10.1007/s12275-017-7089-9 · Cited by 18
A review of N‐acetylcysteine in the treatment of grooming disorders
Braun, T. L., Patel, V., DeBord, L. C., & Rosen, T. (2019) · International Journal of Dermatology · doi:10.1111/ijd.14371 · Cited by 18
Fontani, F., Marcucci, T., Picariello, L., Tonelli, F., VINCENZINI, M. T., & Iantomasi, T. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.02.019 · Cited by 17
Yoon, H., Lee, D. H., Jang, E. S., Kim, J., Shin, C. M., Park, Y. S., Hwang, J., Kim, J., Jeong, S.-H., & Kim, N. (2015) · Gut and Liver · doi:10.5009/gnl15048 · Cited by 16
[Comparison of local acetylcysteine and artificial tears in the management of dry eye syndrome].
Pokupec, R., Petriček, I., Sikić, J., Bradić, M., Popović-Suić, S., & Petriček, G. (2005) · PubMed · Cited by 15
He, G., Li, Q., Li, W., Wang, L., Yang, J., & Zeng, F. (2018) · The Heart Surgery Forum · doi:10.1532/hsf.2193 · Cited by 15
Recycling N-acetylcysteine: A review of evidence for adjunctive therapy in schizophrenia
Willborn, R. J., Hall, C. P., & Fuller, M. A. (2019) · Mental Health Clinician · doi:10.9740/mhc.2019.05.116 · Cited by 15
A pilot study of oxidative pathways in MS fatigue: randomized trial of N‐acetyl cysteine
Krysko, K. M., Bischof, A., Nourbakhsh, B., Henry, R. G., Revirajan, N., Manguinao, M., Nguyen, K., Akula, A. V., Li, Y., & Waubant, E. L. (2021) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51325 · Cited by 15
Rahimi, A., Samimagham, H. R., Hassaniazad, M., Hooshyar, D., Arabi, M., & Jahromi, M. K. (2021) · Trials · doi:10.1186/s13063-021-05242-4 · Cited by 15
N-Acetylcysteine in Patients with Sickle Cell Disease: A Randomized Controlled Trial
Sins, J. W. R., Fijnvandraat, K., Rijneveld, A. W., Boom, M. B., Kerkhoffs, J., van Meurs, A. H., de Groot, M. R., Heijboer, H., Dresse, M., Ferster, A., et al. (2016) · Blood · doi:10.1182/blood.v128.22.123.123 · Cited by 12
N-acetylcysteine for Management of Distal Intestinal Obstruction Syndrome
Schauble, A. L., Bisaccia, E. K., Lee, G., & Nasr, S. Z. (2019) · The Journal of Pediatric Pharmacology and Therapeutics · doi:10.5863/1551-6776-24.5.390 · Cited by 12
Barbosa, A. M., Sarmento-Neto, J. F., de Menezes‐Filho, J. E. R., de Jesus, I. C. G., Souza, D. S., Vasconcelos, V. M. N., Gomes, F. D. D. L., Lara, A., de Araújo, J. S. S., Mattos, S. D. S., et al. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/4850697 · Cited by 11
Chen, C., Luo, J., Fang, Y., Lee, J., Kuo, C.-C., Yang, T., Chiu, M., Yu, J.-J., Bair, M., Chen, P., et al. (2020) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284820927306 · Cited by 9
Allameh, Z. S., Karimi, A., Tabatabaei, S. R., Sharifian, M., & Salamzadeh, J. (2015) · Iranian Journal of Kidney Diseases · Cited by 8
N-acetyl-L-cysteine reduces Leishmania amazonensis-induced inflammation in BALB/c mice
Crupi, R., Gugliandolo, E., Siracusa, R., Impellizzeri, D., Cordaro, M., Paola, R. D., Britti, D., & Cuzzocrea, S. (2020) · BMC Veterinary Research · doi:10.1186/s12917-020-2234-9 · Cited by 8
[A clinical study of N-acetylcysteine treatment in chronic hepatitis B patients].
Wang, N., Shi, X., Shu-hua, G., Zhang, D., & Ren, H. (2008) · PubMed · Cited by 7
Cacciapuoti, F. (2019) · Italian Journal of Medicine · doi:10.4081/itjm.2019.1192 · Cited by 7
Won, H.-R., Lee, G. H., Kim, J. H., Lee, S. H., Kwon, S. Y., Baek, S., Ryu, C. H., Lee, S. J., Park, I., Shin, S.-C., et al. (2020) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-020-03347-y · Cited by 5
Kuzmenko, N., Iaremenko, O. B., Dobrianskiy, D., Ilnytskyi, R. I., & Гуменюк, Г. Л. (2020) · Polish Annals of Medicine · doi:10.29089/2020.20.00112 · Cited by 4
50 Years Ago in The Journal of Pediatrics
Cantú-González, G. (2014) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2014.04.028 · Cited by 3
Chilvers, N. J. S., & Wheeler, J. (2018) · BMJ Case Reports · doi:10.1136/bcr-2017-223965 · Cited by 2
Research works printed but not linked: 4
- PubChem [Internet] (2021, April 29). Bethesda (MD): National Library of Medicine (US), National Center for Biotechnology Information; 2004-PubChem Compound Summary for CID 12035, Acetylcysteine, Available online: https://pubchem.ncbi.nlm.nih.gov/compound/Acetylcysteine.
- Goldenberg, 2012, Multiple sclerosis review, Pharm. Ther., 37, 175
- Ayhan, 2012, Renal functional effects of using N-acetylcysteine in cardiac surgery, Anesth. J., 20, 159
- 2020, N-acetylcysteine as a potential treatment for novel coronavirus disease 2019, Future Microbiol., 15, 959
Cited by
Niu, B., Liao, K., Zhou, Y., Wen, T., Quan, G., Pan, X., & Wu, C. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121110 · Cited by 1,168
Interplay of oxidative stress, cellular communication and signaling pathways in cancer
Iqbal, M. J., Kabeer, A., Abbas, Z., Siddiqui, H. A., Calina, D., Sharifi-Rad, J., & Cho, W. C. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-023-01398-5 · Cited by 418
Chidiac, A. S., Buckley, N. A., Noghrehchi, F., & Cairns, R. (2023) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2023.2223959 · Cited by 215
Rizvi, S. A. A., Einstein, G. P., Tulp, O. L., Sainvil, F., & Branly, R. (2022) · Biomolecules · doi:10.3390/biom12101442 · Cited by 181
“Its toxicity is relatively low and presents mild side effects such as nausea, vomiting, tachycardia, pruritus, and rhinorrhea [145].”
BackgroundKandpal, M., Indari, O., Baral, B., Jakhmola, S., Tiwari, D., Bhandari, V., Pandey, R. K., Bala, K., Sonawane, A., & Jha, H. C. (2022) · Metabolites · doi:10.3390/metabo12111064 · Cited by 159
Metadata
- Authors
- Tenório, M. C. D. S., Graciliano, N. G., Moura, F. A., Oliveira, A. C. M. D., & Goulart, M. O. F.
- Affiliations
- Universidade Federal de Alagoas (BR)
- Corresponding author
- Goulart, Marília Oliveira Fonseca
- ORCID
- Venue
- Antioxidants
- Publisher
- MDPI AG
- Published
- 2021-06-16
- Volume
- 10
- Issue
- 6
- Pages
- 967
- ISSN
- 2076-3921 (ISSN-L)
- PMC
- PMC8234027
- OpenAlex
- W3168473827
- Cited by
- 526
- References
- 205
- Citations by year
- 2026: 115 · 2025: 143 · 2024: 128 · 2023: 79 · 2022: 51 · 2021: 9
- FWCI
- 6.75
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Antioxidants (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (435704/2018-4)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (23038.011373/2017-31)
- Fundação de Amparo à Pesquisa do Estado de Alagoas (60030.0000000192/2021)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Sulfur Compounds in Biology
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Keywords
- N-acetylcysteine, acetaminophen overdose, mucolytic agents, antioxidant activity, anti-inflammatory activity, glutathione, oxidative stress, inflammation, TNF-α, interleukins, NF-κB, drug toxicity, clinical efficacy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.